BOT botanix pharmaceuticals ltd

Ann: Botanix Investor Presentation, page-7

  1. 4,436 Posts.
    lightbulb Created with Sketch. 1531
    As always another professional preso.. some key takeaways I spotted..

    "Competitive products with less ideal safety profiles and potentially poorer efficacy, have generated more than US $1bn per annum"

    "BTX 1503 is a safe and well tolerated topical acne treatment that potentially addresses all the key causes of acne" (Loved the use of the world potentially) -

    "Papulopustular rosacea is a chronic skin disease characterised by redness (inflammation) and acne like break-out

    Hints everywherre.. One must ask why the rosacea now? Perhaps the 'acne like break-out' is the key takeaway? Why chase a similiar market otherwise?

    Join the dots..

    Phase 1B for BTX 1702 will only take 6 weeks also.. then straight on to phase 2 no doubt.

    Also great to see some patent explanation.. that's the beauty of having an ex patent attorney I guess..

    Not sure what else we can ask from management.

    Great work.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
31.0¢
Change
-0.030(8.82%)
Mkt cap ! $607.9M
Open High Low Value Volume
35.0¢ 35.0¢ 31.0¢ $3.301M 9.964M

Buyers (Bids)

No. Vol. Price($)
18 570285 31.0¢
 

Sellers (Offers)

Price($) Vol. No.
32.0¢ 30000 1
View Market Depth
Last trade - 16.10pm 07/07/2025 (20 minute delay) ?
BOT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.